In the Department of Pathology at the University of Edinburgh specimens from pneumonectomy and lobectomy for lung cancer are examined with a standard protocol that involves inflation in formalin and subsequent serial sagittal sectioning of fixed specimens. This procedure allows for preservation of gross morphological detail in the pulmonary parenchyma. Routine blocks are taken from the bronchi, hilar nodes, and tumour as appropriate. It is also our practice to sample macroscopically "normal" pulmonary parenchyma, at least one tissue block being taken from each lobe of lung ifpossible. We review all cases.
The pathogenesis of this tumour is not as clearly defined as that of the more common squamous carcinoma, in which a histological progression from squamous metaplasia of bronchi through dysplasia and carcinoma in situ to invasive malignancy can often be shown. 3 Pulmonary scars have been proposed as precursors of adenocarcinoma but there is much conflicting evidence in this regard. 45 We present data on a distinctive histological lesion that we have found in 10 patients who had pulmonary resection for primary adenocarcinoma. The morphological and immunohistological characteristics of the lesion suggest that it may be important in the histogenesis of parenchymal adenocarcinoma of the lung.
Materials and methods
In the Department of Pathology at the University of Edinburgh specimens from pneumonectomy and lobectomy for lung cancer are examined with a standard protocol that involves inflation in formalin and subsequent serial sagittal sectioning of fixed specimens. This procedure allows for preservation of gross morphological detail in the pulmonary parenchyma. Routine blocks are taken from the bronchi, hilar nodes, and tumour as appropriate. It is also our practice to sample macroscopically "normal" pulmonary parenchyma, at least one tissue block being taken from each lobe of lung ifpossible. We review all cases.
Representative samples of non-tumorous lung tissue received over a five year period (1986-90) were examined for epithelial abnormalities. Between one and five blocks (mean 15) were available from each case. Epithelial changes seen in areas of obstructive pneumonitis or other obvious inflammatory disease were discounted as reactive changes in alveolar lining cells are well recognised in this context. When an area of epithelial abnormality was seen in non-inflamed lung the gross specimen, if available, was reviewed and further tissue blocks were taken. Abnormal epithelial lesions were evaluated immunohistochemically with monoclonal antibodies to PC I0 (a fixation resistance epitope on the proliferating cell number antigen),6 S100, and carcinoembryonic antigen by a standard technique with a horseradish peroxidase conjugated avidin biotin detection system.
Clinical details were obtained for all patients by review of hospital records with particular reference to smoking and occupational history.
Results
In the period 1986-90, 760 possible deregulation of expression of the proliferating cell nuclear antigen gene. This phenomenon has been described in other neoplasms.6 All of the epithelial lesions contained occasional interdigitating S100 positive cells, a pattern similar to that described in many pulmonary adenocarcinomas. Nakanishi'5 has reported a range of typical and atypical changes in the alveolar epithelium from patients coming to surgery for pulmonary adenocarcinoma. At least some of the abnormalities found in these studies correspond to the atypical hyperplasia presented here. In both the studies quoted it is notable that specimens were examined after formalin inflation and serial slicing in a manner similar to the practice in our laboratory. It seems likely that more widespread use of such techniques will reveal more of these subtle parenchymal abnormalities. It is also probable that the incidence of atypical hyperplasia reported here (about 5% of adenocarcinomas) is an underestimate and that a systematic prospective study will produce more of these lesions. Such work is under way in our department. Miller, in a more extensive study of 23 patients,'6 has proposed the term "bronchioalveolar cell adenoma" to describe the lesions referred to here as atypical hyperplasia. We believe that such categorisation of these abnormalities as benign neoplasms of bronchioalveolar type is premature in that, unlike comparable lesions in, for example, the colon, they have not been described except in association with a carcinoma. Further, the associated carcinomas, in our experience, are of parenchymal type, not of the classical bronchioloalveolar morphology.
The concept of a "field change" in an epithelium exposed to carcinogens, with progression from dysplasia and carcinoma in situ to invasive malignancy, is recognised in association with many human and animal tumours. 17 'S Such a progression is well recognised in the case of squamous carcinomas of the lung.3 Indeed bronchial carcinoma in situ is known to be particularly extensive in cases of synchronous multiple primary squamous carcinomas.'9 These changes are strongly related to smoking history. An in situ stage for adenocarcinoma of the lung is not recognised. It is in this context that we describe a dysplastic change in peripheral lung that is strongly associated with parenchymal adenocarcinoma. We believe that these lesions may be important in the pathogenesis of such adenocarcinomas. Further morphological and epidemiological investigation of this disease association will be of great interest.
